Stable demand but geopolitical events having a short-term impact on the business

MAR

Precise Biometrics Interim Report Jan–Mar 2025

First quarter

  • Net sales totaled SEK 20.0 (21.7) million
    • A change in revenue allocation in a renegotiated customer agreement results in higher revenue on an annual basis, but has an impact of SEK -1.0 million on net sales in the first quarter.
  • EBITDA totaled SEK -1.7 (3.1) million
    • Adjusted for negative currency effects from operating items of SEK 1.6 million and a change in revenue allocation in a customer agreement of SEK 1.0 million, EBITDA amounts to SEK 0.9 million
  • Cash flow from operating activities totaled SEK 2.1 (-2.8) million
  • The operating profit/loss (EBIT) totaled SEK -7.1 (-2.8) million
  • Earnings for the period totaled SEK -7.2 (-3.0) million
  • Earnings per share before and after dilution totaled SEK -0.1 (-0.0)
  • ARR (Annual Recurring Revenue) at the end of the period was SEK 18.4 (18.3) million


Significant events during the quarter

  • The anti-spoof solution BioLive approved for national ID program
  • The Nomination Committee proposes Victor Kuzmin for the Board of Directors
  • Entering the Norwegian visitor management system market
  • Expanded biometric physical access offering for high-security sector
  • Showcasing Biometric Security Solutions at ISC West in Las Vegas
  • Västra Hamnen Corporate Finance initiates coverage of Precise
  • Xiaomi launches new smart safe with technology from Precise


Significant events after the end of the interim period

  • Rebranding initiative to clarify and strengthen Precise’s offering


Presentation and Q&A
Precise has published a video interview with CEO Joakim Nydemark in connection with this report.
The video is available on the Investor Relations page: https://precisebiometrics.com/investors/.

The company also invites you to a live Q&A session May 14, 2025, at 13:00 (CET). More information and registration link to the Q&A session may be found on the Investor Relations page: https://precisebiometrics.com/investors/.
The Q&A is in Swedish but questions can be asked in English.

CEO Joakim Nydemark comments

“We continue to see strong demand for our products, and I believe our offering is stronger and more relevant than ever. While our Q1 results did not reach the levels of recent quarters, due to quarterly fluctuations and global market turbulence, I remain positive about the full-year 2025. I view the Q1 outcome as a temporary dip, and we remain fully focused on executing our commercialization strategy and the growth journey that has only just begun.”
Datum 2025-05-14, kl 08:00
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.